Showing results (41-50 of 237) with videos related to
Sort By:
Pageof 24
Controlled Clinical Trials|March 1, 1987
Projection from previous studies: a Bayesian and frequentist compromiseB W Brown, J Herson, E N Atkinson, et al.Current Medical Research and Opinion|February 24, 2009
Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trialsMajid Vakily, Weijiang Zhang, Jingtao Wu, et al.Biochemical Pharmacology|July 15, 1984
Blood and liver acetaldehyde concentrations during ethanol oxidation in C57 and DBA miceC J Eriksson, N Atkinson, D R Petersen, et al.Natural Immunity and Cell Growth Regulation|January 1, 1983
Augmentation of in vitro lymphocyte blastogenesis and cytotoxicity responses by tumor cells modified with dodecanoyl cytochrome CJ W Davis, R S Freedman, N Atkinson, et al.European Journal of Cancer & Clinical Oncology|November 1, 1989
Treatment of advanced endometrial adenocarcinoma with cyclic sequential ethinyl estradiol and medroxyprogesterone acetateJ L Tatman, R S Freedman, W Scott, et al.The Medical Journal of Australia|July 1, 2016
Uptake of long-acting, reversible contraception in three remote Aboriginal communities: a population-based studyEmma K Griffiths, Julia V Marley, Domenica Friello, et al.Organic & Biomolecular Chemistry|November 22, 2017
Regioselective and enantiospecific synthesis of the HSP co-inducer arimoclomol from chiral glycidyl derivativesBenjamin N Atkinson, Hannah L Woodward, James Sipthorp, et al.Journal of Medicinal Chemistry|May 29, 1999
Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthaseK Ichimori, D J Stuehr, R N Atkinson, et al.The British Journal of Clinical Practice|November 1, 1990
A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group studyN D Chapman, M G Grillage, R Mazumder, et al.Alimentary Pharmacology & Therapeutics|February 27, 2009
Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor--evidence for dosing flexibilityR D Lee, M Vakily, D Mulford, et al.Pageof 24